Skip to content

Ozempic · Insurance coverage

Ozempic insurance coverage

How plans usually handle Ozempic, what prior authorization asks for and how appeals work.

Clinician review pending Updated

How plans usually cover it

  • Most plans cover GLP-1 medicines for type 2 diabetes, often with prior authorization to confirm the diagnosis.
  • Some plans require you to try metformin or a preferred brand first (step therapy).
  • Medicare Part D generally covers these medicines for type 2 diabetes.
  • Plans may audit for off-label use for weight loss and deny claims without a diabetes diagnosis.

Prior authorization, step by step

  1. Check the formularyLook up Ozempic in your plan's drug list and note any prior authorization or step-therapy flags.
  2. Gather the evidenceYour prescriber records the diagnosis (type 2 diabetes) and any weight-related conditions.
  3. Prescriber submitsThe office sends the request, often through an electronic system. Decisions usually take days, not weeks.
  4. If denied, appealAsk for the denial reason in writing. An appeal letter answers that exact reason with chart evidence.
  5. RenewalsPlans often re-check after 3 to 6 months and may require documented progress.

Appeal letter outline

  1. Patient name, plan ID and the claim or reference number.
  2. The medicine, dose and diagnosis codes.
  3. The plan's stated denial reason, quoted.
  4. Evidence that answers it: BMI, conditions, prior treatments tried.
  5. The FDA-approved use that matches the patient.
  6. The prescriber's signature and contact details.

Full guide: getting a GLP-1 prior authorization approved. Medicare details: Medicare and GLP-1s.

Common questions

Does insurance cover Ozempic?

It depends on your plan. Most plans cover GLP-1 medicines for type 2 diabetes, often with prior authorization to confirm the diagnosis.

Does Ozempic need prior authorization?

Often, yes. Plans usually want the diagnosis and supporting chart notes before approving it.

What if my Ozempic claim is denied?

Ask for the reason in writing and have your prescriber file an appeal that answers that reason directly.

Sources

  1. Ozempic prescribing information (FDA label on DailyMed)

Clinician review pending. Drafted from primary sources and waiting for sign-off by a licensed clinician (MD, DO or PharmD) before launch. Every number is checked against its source. Drug facts are re-checked quarterly, prices monthly and whenever a label changes. How we review · Report an error